Inventor · disambiguated record
Tatiana Novobrantseva
Also filed as: NOVOBRANTSEVA TATIANA · NOVOBRANTSEVA TATIANA I
30 granted patents·32 pending applications·104 citations·filing 2006–2025
96Inventor score
Files withALNYLAM PHARMACEUTICALS INC27DE FOUGEROLLES ANTONIN8VERSEAU THERAPEUTICS INC6ARBUTUS BIOPHARMA CORP5JOUNCE THERAPEUTICS INC2
Top patents by PatentIndex Score
62 records- 0195US8546554B2Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A geneDE FOUGEROLLES ANTONIN·Filed 2009·Granted Oct 1, 2013·25 cites·23 claims
- 0291US10745704B2Compositions and methods for inhibiting expression of CD274/PD-L1 geneALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Aug 18, 2020·3 cites·13 claims
- 0391US8507663B2Compositions and methods for inhibiting expression of CD274/PD-L1 geneDEFOUGEROLLES ANTONIN·Filed 2011·Granted Aug 13, 2013·22 cites·16 claims
- 0490US2024327834A1Lipid formulated compositions and methods for inhibiting expression of serum amyloid a geneALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0589US10626176B2Methods of treating conditions with antibodies that bind B7-H4JOUNCE THERAPEUTICS INC·Filed 2015·Granted Apr 21, 2020·8 cites·2 claims
- 0689US9422562B2Compositions and methods for inhibiting expression of CD274/PD-L1 geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Aug 23, 2016·8 cites·13 claims
- 0787US7759320B2Compositions and methods for inhibiting expression of a gene from the EbolaALNYLAM PHARMACEUTICALS INC·Filed 2008·Granted Jul 20, 2010·6 cites·21 claims
- 0886US7871985B2Compositions and methods for inhibiting expression of factor VII geneALNYLAM PHARMACEUTICALS INC·Filed 2008·Granted Jan 18, 2011·5 cites·19 claims
- 0982US8227188B2Enhancement of influenza gene expressionDE FOUGEROLLES ANTONIN·Filed 2010·Granted Jul 24, 2012·4 cites·19 claims
- 1081US11884919B2Lipid formulated compositions and methods for inhibiting expression of serum amyloid a geneALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Jan 30, 2024·0 cites·16 claims
- 1181US10472628B2Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A geneALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Nov 12, 2019·1 cites·18 claims
- 1280US8617545B2Methods for use with BAFF antagonistsHSU YEN-MING·Filed 2006·Granted Dec 31, 2013·8 cites·7 claims
- 1379US9944671B2Compositions and methods directed to treating liver fibrosisHINKLE GREG·Filed 2011·Granted Apr 17, 2018·6 cites·8 claims
- 1478US11149273B2Lipid formulated compositions and methods for inhibiting expression of serum amyloid A geneALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Oct 19, 2021·0 cites·17 claims
- 1577US2022074925A1Screening method for selected amino-lipid-containing compositionsARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 1676US9868950B2Lipid formulated compositions and methods for inhibiting expression of serum amyloid A geneALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Jan 16, 2018·1 cites·21 claims
- 1776US2025346906A1Compositions and methods for inhibiting expression of cd274/pd-l1 geneALNYLAM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1875US9062310B2Compositions and methods for inhibiting expression of factor VII geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Jun 23, 2015·1 cites·19 claims
- 1975US2011097720A1Screening method for selected amino lipid-containing compositionsALNYLAM PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2074US8735369B2Compositions and methods for inhibiting expression of a gene from the Ebola virusALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted May 27, 2014·1 cites·17 claims
- 2174US8288525B2Compositions and methods for inhibiting expression of CD45 geneDE FOUGEROLLES ANTONIN·Filed 2009·Granted Oct 16, 2012·1 cites·14 claims
- 2274US2020225215A1Screening method for selected amino-lipid-containing compositionsARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 2373US8664193B2Compositions and methods for inhibiting expression of factor VII geneDE FOUGEROLLES ANTONIN·Filed 2012·Granted Mar 4, 2014·1 cites·23 claims
- 2473US8334273B2Compositions and methods for inhibiting expression of factor VII geneDE FOUGEROLLES ANTONIN·Filed 2010·Granted Dec 18, 2012·1 cites·25 claims
- 2571US2021155937A1Compositions and methods for inhibiting expression of cd274/pd-l1 geneALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2669US9029338B2Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virusDE FOUGEROLLES ANTONIN·Filed 2010·Granted May 12, 2015·1 cites·16 claims
- 2768US2022079970A1Methods of delivering oligonucleotides to immune cellsARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 2868US2018209963A1Screening method for selected amino-lipid-containing compositionsARBUTUS BIOPHARMA CORP·Filed 2017·Application pending·0 cites
- 2966US10669303B2Compositions and methods directed to treating liver fibrosisALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Jun 2, 2020·0 cites·13 claims
- 3066US9206421B2Lipid formulated compositions and methods for inhibiting expression of serum amyloid A geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Dec 8, 2015·0 cites·18 claims
- 3166US9187516B2Compositions and methods for inhibiting expression of a gene from the Ebola virusALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·0 cites·17 claims
- 3264US2021285931A1Assays for the detection of aav neutralizing antibodiesVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3364US2014295449A1Screening method for selected amino lipid-containing compositionsTEKMIRA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3463US2021087218A1Compositions and methods directed to treating liver fibrosisALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3563US2012225434A1Screening method for selected amino lipid-containing compositionsCIUFOLINI MARCO A·Filed 2012·Application pending·0 cites
- 3663US2016274089A1Screening method for selected amino-lipid-containing compositionsTEKMIRA PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 3762US9932593B2Compositions and methods for inhibiting expression of CD274/PD-L1 geneALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·0 cites·12 claims
- 3861US10983110B2Assays for the detection of AAV neutralizing antibodiesVOYAGER THERAPEUTICS INC·Filed 2016·Granted Apr 20, 2021·0 cites·22 claims
- 3960US8865645B2Method of treating lung fibrosis using ST2 polypeptideAMATUCCI ALDO·Filed 2007·Granted Oct 21, 2014·1 cites·11 claims
- 4060US8354390B2Compositions and methods for inhibiting expression of a gene from the ebola virusALNYLAM PHARMACEUTICALS INC·Filed 2011·Granted Jan 15, 2013·0 cites·17 claims
- 4159US2015093417A1Compositions And Methods For Inhibiting Expression Of CD45 GeneALNYLAM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4258US8912316B2Compositions and methods for inhibiting expression of CD45 geneDE FOUGEROLLES ANTONIN·Filed 2012·Granted Dec 16, 2014·0 cites·23 claims
- 4358US7973020B2Compositions and methods for inhibiting expression of a gene from the ebola virusALNYLAM PHARMACEUTICALS INC·Filed 2010·Granted Jul 5, 2011·0 cites·9 claims
- 4458US2014288154A1Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 And VEGF GenesALNYLAM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4557US2016264972A1Compositions and Methods for Inhibiting Expression of a Gene from the Ebola VirusALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4655US2016017336A1Compositions and methods for inhibiting expression of factor vii geneALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4755US2014213470A1Methods for use with baff antagonistsGENENTECH INC·Filed 2013·Application pending·0 cites
- 4854US2018369271A1Methods of delivering oligonucleotides to immune cellsARBUTUS BIOPHARMA CORP·Filed 2018·Application pending·0 cites
- 4953US2011045473A1Liver screening methodDE FOUGEROLLES ANTONIN·Filed 2008·Application pending·0 cites
- 5052US2007197460A1Rnai inhibition of influenza virus replicationALNYLAM PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tatiana Novobrantseva files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →